about
Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR studyCytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis.Correction: Cytoskeletal Rearrangements in Synovial Fibroblasts as a Novel Pathophysiological Determinant of Modeled Rheumatoid ArthritisRevisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In SilicoAnalysis of time to event outcomes in randomized controlled trials by generalized additive modelsModeling bias and variation in the stochastic processes of small RNA sequencing.Urinary microRNA profiling in the nephropathy of type 1 diabetes.Dialyzer Reuse and Outcomes of High Flux DialysisUrinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes.Objective and subjective sleep disorders in automated peritoneal dialysis.MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.Impact of fatigue on outcomes in the hemodialysis (HEMO) studyThe hazards of the changing hazard of dialysis modalities.Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies.Restoration of high-frequency glucose-entrained insulin oscillations in obese subjects with type 2 diabetes after biliopancreatic diversion.Background adjustment of cDNA microarray images by Maximum Entropy distributions.Study protocol: rationale and design of the community-based prospective cohort study of kidney function and diabetes in rural New Mexico, the COMPASS study.Sleep quality, mood, alertness and their variability in CKD and ESRD.Successful treatment with thalidomide in a liver transplant recipient with giant esophageal ulcersIndices of serum tonicity in clinical practiceBeta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies
P50
Q21131891-5779150E-586D-4473-9480-B6865EDBD74DQ24810942-B5A65F14-8712-4C0A-93F5-A032A3E128C4Q24811206-7F4A487B-D4ED-404E-9AC8-E74A5F6329D8Q27009538-767DA471-C4F4-4197-9DBA-84201994856CQ27309297-871E274F-2119-472F-93EB-80A4033F8E53Q33878956-810655A7-86EA-436D-BB50-7D45CC8A73DAQ34566051-175525FD-5BCC-4389-A1DD-87452140543CQ35658056-4D82C3CA-F02C-4B11-931F-A95FA367B993Q35902228-BB36FA0D-E417-481A-8EA5-71D235B24AA9Q36587939-A4F74471-37DF-45E0-A9BD-E4F1FBE6EC2FQ38754415-6BAE59A2-E3B4-45AF-818A-01E4E77A09EBQ41632999-38077657-FBC0-4879-82C2-DFD12BF81F53Q44108532-9DF57303-DB9C-423E-B3E1-9542E7B0623FQ47396865-9D4679BE-96BC-406D-A810-519747506B56Q47741066-145731A1-C987-41A0-99CD-D21BA4F046D5Q51709372-21C233A6-ED20-48F3-B391-10383B6942D9Q52682754-A7AB8C12-7CEB-4639-8D04-BA5F3CE8A0BAQ53084876-6D3DA531-101E-45DA-9FE7-C0738484C4F9Q83835450-84FC521D-0252-4CF8-BED3-49D4D5BCEB84Q85197209-418EB5DA-273B-4B02-AA6C-7091F8E02A7BQ89861207-44D623D8-17F3-4563-AC63-49C9BE21E3A9
P50
description
researcher ORCID: 0000-0002-9679-7805
@en
wetenschapper
@nl
name
Christos Argyropoulos
@ast
Christos Argyropoulos
@en
Christos Argyropoulos
@es
Christos Argyropoulos
@nl
Christos Argyropoulos
@sl
type
label
Christos Argyropoulos
@ast
Christos Argyropoulos
@en
Christos Argyropoulos
@es
Christos Argyropoulos
@nl
Christos Argyropoulos
@sl
prefLabel
Christos Argyropoulos
@ast
Christos Argyropoulos
@en
Christos Argyropoulos
@es
Christos Argyropoulos
@nl
Christos Argyropoulos
@sl
P106
P2798
P31
P3835
christos-argyropoulos2
P496
0000-0002-9679-7805